KLK3 and prostate carcinoma: Another HSV-1 virus variant, NV1020, was found to cause tumor lysis in all prostate cancer cell lines tested in vitro, as well as a reduction in serum PSA and tumor suppression following injection into thymus-free mice inoculated with PC-3 and C4-2 human prostate cancer [184].